- Home
- KLIC vs GH Comparison
KLIC vs GH Comparison
Compare KLIC & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLIC
- GH
- Stock Information
- Founded
- KLIC 1951
- GH 2011
- Country
- KLIC United States
- GH United States
- Employees
- KLIC N/A
- GH N/A
- Industry
- KLIC Semiconductors
- GH Medical Specialities
- Sector
- KLIC Technology
- GH Health Care
- Exchange
- KLIC Nasdaq
- GH Nasdaq
- Market Cap
- KLIC 2.7B
- GH 2.7B
- IPO Year
- KLIC N/A
- GH 2018
- Fundamental
- Price
- KLIC $49.17
- GH $32.65
- Analyst Decision
- KLIC Strong Buy
- GH Strong Buy
- Analyst Count
- KLIC 5
- GH 15
- Target Price
- KLIC $52.40
- GH $39.93
- AVG Volume (30 Days)
- KLIC 668.6K
- GH 2.2M
- Earning Date
- KLIC 11-13-2024
- GH 11-06-2024
- Dividend Yield
- KLIC 1.63%
- GH N/A
- EPS Growth
- KLIC N/A
- GH N/A
- EPS
- KLIC N/A
- GH N/A
- Revenue
- KLIC $706,232,000.00
- GH $692,256,000.00
- Revenue This Year
- KLIC $15.03
- GH $31.00
- Revenue Next Year
- KLIC $11.34
- GH $17.55
- P/E Ratio
- KLIC N/A
- GH N/A
- Revenue Growth
- KLIC N/A
- GH 29.20
- 52 Week Low
- KLIC $38.20
- GH $15.81
- 52 Week High
- KLIC $56.71
- GH $37.04
- Technical
- Relative Strength Index (RSI)
- KLIC 61.42
- GH 74.18
- Support Level
- KLIC $45.21
- GH $28.45
- Resistance Level
- KLIC $51.32
- GH $32.26
- Average True Range (ATR)
- KLIC 1.90
- GH 1.79
- MACD
- KLIC 0.03
- GH 0.41
- Stochastic Oscillator
- KLIC 68.20
- GH 90.45
About KLIC Kulicke and Soffa Industries Inc.
Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments which includes Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.